NOT KNOWN FACTS ABOUT COPYRIGHT 1 MG-SEMAGLUTIDE

The trial realized each its Most important endpoints, with semaglutide two.four mg demonstrating statistically major and exceptional improvements in liver fibrosis without worsening of steatohepatitis, and resolution of steatohepatitis without any worsening of liver fibrosis in individuals with MASH in comparison to placebo.1The developmental and h